New plasma cancer treatment kills malignant cells
CAPS Medical’s delivery system sends high-energy ionized gas to kill malignant cells inside a tumor. The first indication is bladder cancer.
CAPS Medical’s delivery system sends high-energy ionized gas to kill malignant cells inside a tumor. The first indication is bladder cancer.
Israel’s Vessi Medical aims to reduce the rate of recurrence by destroying non-muscle invasive bladder tumors with cryoablation.
Nucleix has received European Union approval to market Bladder EpiCheck test for cancer follow-up. A blood screening for lung cancer is in the works.
Nucleix is making a simple urine test to monitor the disease, which has the highest lifetime treatment cost per patient of all types of cancer.
Two promising Israeli treatments target common conditions affecting millions of men across the world.